Amaia Latasa Arrazubi Institutions of which they are part Gestió i Administració Commercial and Academic Clinical Research Vall Hebron Institut de Recerca Email Amaia Latasa Arrazubi Email Institutions of which they are part Gestió i Administració Commercial and Academic Clinical Research Vall Hebron Institut de Recerca
Projects Plataforma de soporte para la Investigación Clínica IP: Inmaculada Fuentes Camps Collaborators: Antonio Moreno Galdó, Rafael Simó Canonge, Ariadna Martín Balcells, Mª Eulàlia Molinas Guilera, Olga Sánchez- Maroto Carrizo, Angelica Valderrama Rodríguez, Amaia Latasa Arrazubi, Joan Genescà Ferrer, Gemma Vona Giralt, Paula Isabel Roldan Caballero Funding agency: Instituto de Salud Carlos III Funding: 274920 Reference: PT23/00062 Duration: 01/01/2024 - 31/12/2026 RBDCOV: RBD Dimer recombinant protein vaccine against SARSCoV2 IP: Pere Soler Palacín Collaborators: Noemí Giménez Sanz, Ariadna Martín Balcells, Miriam Gonzalez Amores, Olga Sánchez- Maroto Carrizo, Amaia Latasa Arrazubi Funding agency: EUROPEAN COMMISSION Funding: 525423.93 Reference: RBDCOV_P.SOLER_HE_2021 Duration: 01/12/2021 - 31/08/2025 Immune profiling to guide host-directed interventions to cure HBV infections IP: Maria Buti Ferret Collaborators: Maria del Mar Riveiro Barciela, Judit Romero Vico, Judit Romero Vico, Mª Eulàlia Molinas Guilera, Amaia Latasa Arrazubi Funding agency: EUROPEAN COMMISSION Funding: 211443.8 Reference: IP-CURE-B_H2020SC1BHC2019 Duration: 01/01/2020 - 31/12/2025 LIVERHOPE: SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS IP: - Collaborators: Ester Palacio Gutierrez, Mª Eulàlia Molinas Guilera, Olga Sánchez- Maroto Carrizo, Amaia Latasa Arrazubi, Joan Genescà Ferrer Funding agency: EUROPEAN COMMISSION Funding: 409557 Reference: LIVERHOPE_VM.VARGAS_H2020_2016 Duration: 01/01/2017 - 28/02/2023 Pagination Current page 1 Page 2 Next page › Last page »
